cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Anixa Biosciences Inc
7 own
6 watching
Current Price
$3.66
$0.16
(4.57%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
106.9M
52-Week High
52-Week High
5.13000
52-Week Low
52-Week Low
2.15000
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization106.9M
icon52-Week High5.13000
icon52-Week Low2.15000
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Anixa Biosciences Inc do?
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company s therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Read More
How much money does Anixa Biosciences Inc make?
News & Events about Anixa Biosciences Inc.
Ticker Report
1 year ago
Rezolute (NASDAQ:RZLT Get Rating) and Anixa Biosciences (NASDAQ:ANIX Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, ...
PR Newswire
1 year ago
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine PR Newswire SAN JOSE, Calif., April 17, 2023 Immune responses were observed at all dose...
PR Newswire
1 year ago
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting PR Newswire SAN JOSE, Calif., March 27, 2023 SAN JOSE, Calif., March 27, 2023 /PRNewswire...
PR Newswire
1 year ago
Anixa Biosciences to Present at Biotech Showcase 2023 Anixa Biosciences to Present at Biotech Showcase 2023 PR Newswire SAN JOSE, Calif., Dec. 19, 2022 SAN JOSE, Calif., Dec. 19, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and...
PR Newswire
2years ago
Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy PR...
Frequently Asked Questions
Frequently Asked Questions
What is Anixa Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Anixa Biosciences Inc shares?
plus_minus_icon
How can I buy Anixa Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Anixa Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Anixa Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Anixa Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Anixa Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Anixa Biosciences Inc?
plus_minus_icon
What percentage is Anixa Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Anixa Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.66
$0.16
(4.57%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00